David Gally

Search results

• Active

  IDG2023/28 - PP2024 - Capability - Testing establishment of MDR Escherichia coli ST131 in the pig gastrointestinal tract and impact of phage intervention in vivo and in bioreactors

  Gally, D., Glendinning, L., Muwonge, A., Paterson, G., Stevens, M. & Woods, G.

  BBSRC

  1/07/24 → 31/03/25

  Project: Research

• ISP 2023/28 Consumables - Bacteriology

  Whitelaw, B., Fitzgerald, R., Fitzgerald, R., Gally, D., Stevens, M. & Stevens, J.

  BBSRC

  1/04/23 → 31/03/28

  Project: Research

• Alignment of sequence-based diagnostics and combinatorial phage therapy for treatment of chronic canine urinary tract infections

  Gally, D.

  Dogs Trust

  1/02/23 → 31/01/25

  Project: Research

• Defining the physiology of E. coli O157:H7 in cattle to develop phage-based interventions

  Gally, D.

  BBSRC

  1/01/23 → 31/12/25

  Project: Research

• Defining the physiology of E. coli O157:H7 in cattle to develop phage-based interventions

  Gally, D.

  BBSRC

  1/01/23 → 31/03/26

  Project: Research

• EPO funding for studentship: Advancing phage therapy for human urinary tract infections

  Gally, D.

  Proteon Pharmaceuticals S.A.

  3/10/22 → 2/10/26

  Project: Research

• Studentship: Advancing phage therapy for human urinary tract infections

  Gally, D.

  Medical Research Scotland

  3/10/22 → 2/10/26

  Project: Research